Fulcrum Therapeutics, Inc. · NASDAQ:FULC

EcoR1 Capital, LLC reported a 9.00% stake in Fulcrum Therapeutics, Inc. (Schedule 13G)

Event Jun 17, 2026 · Filed Jun 25, 2026

EcoR1 Capital, LLC reported a 9.00% stake in Fulcrum Therapeutics, Inc., 6,000,000 shares, as a passive investor on Jun 17, 2026. Filed Jun 25, 2026 (Schedule 13G).

Stake
9.00%
Shares
6,000,000
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
EcoR1 Capital, LLC9.00%6,000,000
Oleg Nodelman9.00%6,000,000
EcoR1 Capital Fund Qualified, L.P.8.40%5,614,199

Source

View original at SEC

Related